Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Terra Balcanica Drills 636 g/t Ag Eq. Over 4.3 m At Cumavici Ridge in Bosnia and Herzegovina
-
Outdoor Holding Company Reaches Settlement with Digital Cash Processing
-
ARS Pharmaceuticals Announces Conference Call and Webcast for its Fourth Quarter and Full Year 2025 Financial Results and Participation at Upcoming Conferences
-
Mount Logan Capital Inc. Announces $10 Million Share Repurchase Program
-
Pliant Therapeutics to Participate in the Oppenheimer Healthcare Life Science Conference
-
Axonius Appoints Meghan Marks as Chief Marketing Officer to Drive Category Leadership and Market Expansion
-
Kratos and GE Aerospace Win U.S. Air Force Award to Design Engine for Expendable Combat Collaborative Aircraft
-
Acres.com and Hamlet Partner to Bring Local Government Sentiment Data to Land Intelligence
-
Boston Legacy FC Announces Sensory Room Sponsorship with Collegium Pharmaceutical
-
VenHub Introduces Self-Diagnosing Robotics to Maximize Uptime Across Smart Stores
-
Verrica Pharmaceuticals to Participate in the TD Cowen 46th Annual Health Care Conference
-
Phathom Pharmaceuticals to Participate in Upcoming Investor Conferences
-
Mod Op Launches “Mod Op AI Risk Intelligence” to Audit Harmful AI-Generated Content
-
Alignment Healthcare to Present at the Leerink Partners Global Healthcare Conference
-
First Patient Receives FDA-Authorized Clairity Breast Score, Marking a New Era in AI Empowered Breast Cancer Risk Assessment
-
Learning Care Group Solves Summer Scheduling Woes for Working Families
-
UroGen Pharma to Report Fourth Quarter and Full-Year 2025 Financial Results on Monday, March 2, 2026
-
Sionna Therapeutics to Participate in Upcoming March 2026 Investor Conferences
-
Southwest Strategies Group Rebrands as Bodewell Group Following Sustained Growth and Strategic Acquisitions
-
LENZ Therapeutics to Present at Upcoming Investor Conferences
-
Cerevance to Participate in the TD Cowen 46th Annual Health Care Conference
-
Aligos Therapeutics Presents Positive Data at the Conference on Retroviruses and Opportunistic Infections (CROI)
-
Offer Update
-
ASML reports transactions under its current share buyback program
-
Artios Receives U.S. FDA Fast Track Designation for DNA Polymerase Theta (Polθ) Inhibitor ART6043 for Treatment of gBRCA-mutated HER2-Negative Breast Cancer
-
Uni-Fuels Expands Southeast Asia Footprint with New Regional Office in Thailand
-
Recursion to Participate in Upcoming Investor Conferences
-
FLSmidth & Co. A/S: Trading in FLSmidth shares by board members, executives and associated persons
-
Virtuix to Host Third Quarter Fiscal Year 2026 Results Conference Call on Thursday, March 5, 2026 at 8:30 a.m. Eastern Time
-
South Plains Financial, Inc. Announces Stock Repurchase Program
-
TG Therapeutics to Host Conference Call on Fourth Quarter and Full Year 2025 Financial Results and Business Update
-
Aptima to Facilitate NASA RAM-AO Working Group to Advance Autonomous Multi-Aircraft Operations
-
ASP Isotopes Announces Quantum Leap Energy and Necsa Advance Strategic Collaboration Aimed at Production of HALEU Nuclear Fuel
-
Anavex Life Sciences Appoints Seasoned Healthcare Leader to Board of Directors
-
Crescent Biopharma to Present at March Investor Conferences
-
Verisk Analytics, Inc. Enters into $1.5 Billion Accelerated Share Repurchase Transaction
-
U.S. FDA Grants Reunion Neuroscience’s Luvesilocin (RE104) Breakthrough Therapy Designation Status
-
BridgeBio to Participate in March Investor Conferences
-
Novo Nordisk A/S - share repurchase programme
-
Borregaard ASA: Reporting of transactions in Borregaard ASA's shares made by person discharging managerial responsibilities
-
New, Patent-Pending Tubing Anchor Catcher Now Available from TechTAC
-
Reliance Global Group Closes Enquantum Transaction, Launching Path to Majority Control of Post-Quantum Cybersecurity Platform
-
Notice of Extraordinary General Meeting, proposed company dissolution and delisting
-
NOTICE OF CORRECTION TO NOTICE DATED 18 FEBRUARY 2026 IN RESPECT OF TIME OF MEETING RELATING TO A PROPOSED AMENDMENT TO THE PRINCIPAL AMOUNT OF THE AFFECTED SECURITIES
-
Rail Vision Regains Compliance with Nasdaq Minimum Bid Price Requirement
-
Preliminary financial results for 2025 and guidance for 2026
-
C4 Therapeutics to Participate in Upcoming March Conferences
-
Cyber Acoustics Celebrates 30 Years of Audio Innovation
-
uniQure to Announce 2025 Financial Results
-
Kraig Biocraft Laboratories’ Spider Silk Advancements Featured as the Cover of National Geographic's March 2026 Issue

